Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes (Q37973657)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

title

Beyond lung function in COPD management: effectiveness of LABA/LAMA combination therapy on patient-centred outcomes (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

1 reference

Thys van der Molen

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

Mario Cazzola

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

language of work or name

1 reference

1 March 2012

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

Primary care respiratory journal : journal of the General Practice Airways Group

19 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

volume

21

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

page(s)

101-108

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

Effects of tiotropium with and without formoterol on airflow obstruction and resting hyperinflation in patients with COPD.

19 January 2020

cites work

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Pharmacologic interventions in chronic obstructive pulmonary disease: bronchodilators

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

The scientific rationale for combining long-acting beta2-agonists and muscarinic antagonists in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Formoterol mono- and combination therapy with tiotropium in patients with COPD: a 6-month study

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Outcomes and markers in the assessment of chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Outcomes for COPD pharmacological trials: from lung function to biomarkers.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Dynamic hyperinflation: is it worth measuring?

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Inspiratory capacity and decrease in lung hyperinflation with albuterol in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Effects of arformoterol twice daily, tiotropium once daily, and their combination in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Effects of tiotropium and formoterol on dynamic hyperinflation and exercise endurance in COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Efficacy and safety of nebulized formoterol as add-on therapy in COPD patients receiving maintenance tiotropium bromide: Results from a 6-week, randomized, placebo-controlled, clinical trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Formoterol and tiotropium compared with tiotropium alone for treatment of COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Concomitant treatment with nebulized formoterol and tiotropium in subjects with COPD: a placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Combining tiotropium and salmeterol in COPD: Effects on airflow obstruction and symptoms

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Comparison of tiotropium once daily, formoterol twice daily and both combined once daily in patients with COPD.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Development, validity and responsiveness of the Clinical COPD Questionnaire

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Development and first validation of the COPD Assessment Test

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Cardiovascular safety of QVA149, a combination of Indacaterol and NVA237, in COPD patients

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Emerging inhaled bronchodilators: an update

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

QVA149 demonstrates superior bronchodilation compared with indacaterol or placebo in patients with chronic obstructive pulmonary disease

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Relation of chronic obstructive pulmonary disease exacerbations to FEV(1)--an intricate tango

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Predictors of COPD symptoms: does the sex of the patient matter?

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Lung function decline and outcomes in an elderly population.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Physical activity, spirometry and quality-of-life in chronic obstructive pulmonary disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.4104%2FPCRJ.2011.00102

Methodological issues in evaluating measures of health as outcomes for COPD.

21 January 2018

1 reference

12 December 2020

Long-acting bronchodilators are the first-choice option for the treatment of stable COPD

1 reference

12 December 2020

A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire

1 reference

12 December 2020

Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease: a randomized trial

1 reference

12 December 2020

Spirometric correlates of dyspnea improvement among emergency department patients with chronic obstructive pulmonary disease exacerbation

1 reference

12 December 2020

Impact of frequency of COPD exacerbations on pulmonary function, health status and clinical outcomes

1 reference

12 December 2020

Comparison of tiotropium plus formoterol to tiotropium alone in stable chronic obstructive pulmonary disease: a meta-analysis

1 reference

12 December 2020

Pulmonary mechanics during exercise in subjects with chronic airflow obstruction

1 reference

12 December 2020

Identifiers

DOI

10.4104/PCRJ.2011.00102

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

19 January 2020

1012615502

0 references

Fatcat ID

release_iuftwxhqy5gytdqeoqryt6lhuq

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/iuftwxhqy5gytdqeoqryt6lhuq

24 November 2022

mapped directly with Wikidata item

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json

19 January 2020

PubMed publication ID

22222945

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:22222945%20AND%20SRC:MED&resulttype=core&format=json